Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05217849 · ClinicalTrials.gov registry record · NA

Multi-domain Online Therapeutic Investigation Of Neurocognition (MOTION)

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
77
Enrollment target

NCT05217849: Completed NA study, sponsored by University of California, San Francisco.

NCT05217849 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05217849, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effects of three on-line wellness interventions for improving physical and cognitive function and brain connectivity in adults who are at least 55 years old and are experiencing symptoms of memory and/or cognitive difficulties.

Primary Outcome

The Alzheimer's Disease Assessment Scale-Cognitive Subscale is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. ADAS-cog scores range from 0-70, with higher scores (≥ 18) indicating greater cognitive impairment.

Interventions

  • BEHAVIORAL Tai Chi
  • BEHAVIORAL Preventing Loss of Independence through Exercise (PLIE)
  • BEHAVIORAL Health and Wellness Education

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2022-02-15
Est. Completion 2025-12-31
Phase NA

What the finished NCT05217849 record still lists

NCT05217849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Tai Chi is the first listed.

NCT05217849 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05217849 about?

NCT05217849 is a clinical study titled "Multi-domain Online Therapeutic Investigation Of Neurocognition (MOTION)". The purpose of this study is to compare the effects of three on-line wellness interventions for improving physical and cognitive function and brain connectivity in adults who are at least 55 years old and are experiencing symptoms of memory and/or cognitive difficulties.

What is the current status of trial NCT05217849?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2022-02-15. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT05217849?

The interventions under investigation include: Tai Chi (BEHAVIORAL), Preventing Loss of Independence through Exercise (PLIE) (BEHAVIORAL), Health and Wellness Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05217849?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05217849's enrollment target sits among peer trials

77 1062nd of 2000 higher than 939 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05217849, the US trial registry maintained by the National Library of Medicine. NCT05217849 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.